ILMN vs INMD: fair value comparison
Illumina, Inc. and InMode Ltd. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, INMD currently sits closer to the top of our discount ranking.
| ILMN | INMD | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $198.16 | $15.35 |
| 12-month range | $97.82–$198.16 | $13.59–$16.62 |
| Sector rank | #98 of 113 Healthcare | #94 of 113 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Low |
| Margin trend | Expanding | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: ILMN fair value analysis · INMD fair value analysis